STATUS / ACCESS RECORD BPC-157 legal status, FDA 503A category, and compounding access The current FDA position, read present-tense and cited plus the scheduled July 2026 evaluation that has BPC-157 named by FDA as a substance under active review
It is a synthetic analogue of the naturally occurring GHK, differing from it at a single position: alanine in place of glycine at the first residue
general fatigue, hangovers, acne, eczema, hives, dermatitis, allergies
Through genetic tests and detailed lab work, doctors could select the appropriate peptide and dosage for each individual
Moro, F
A process called central sensitization can make widespread neural pathways hypersensitive, causing itch signals to fire across a broad area rather than at a single point